Cut 2 stocks and buy 2 other laggards
On Monday morning, we will execute four trades. Shortly after the opening bell, we will sell 100 shares of Danaher…
health care industry
FDA approves new blood test to detect colon cancer
The Food and Drug Administration approved on Monday 'Guardian Health'The blood test, called Shield, is used to detect colon cancer.…
These drugmakers are catching up to Eli Lilly and Novo Nordisk
The lucrative market for weight-loss drugs won’t be a duopoly forever. With billions at stake, that’s been a virtual guarantee…
Dexcom shares fall more than 40% after second-quarter results
Dexcom Shares fell more than 40% on Friday and were on track for their worst day ever after the diabetes…
A poor earnings report from a competitor is good news for Abbott Labs
Every weekday, the CNBC Investment Club with Jim Cramer hosts a live “Morning Meeting” broadcast at 10:20 a.m. ET. Here’s…
Biogen Eisai's Leqembi Alzheimer's drug rejected by EU regulator
European drug regulators on Friday rejected Leqembi's Alzheimer's treatment Biogen and Eisaicreating another hurdle for companies as they struggle to…
Bristol Myers Squibb (BMY) Q2 2024 Results
Bristol Myers Squibb's research and development center at Cambridge Crossing in Cambridge, Massachusetts, on December 27, 2023. Adam Glanzman |…
Fund manager of names in weight loss and biotechnology
Weight-loss drugs have sparked investor interest and shaken up other sectors over the past year. Novo Nordisk and Eli Lilly…
Dexcom shares fall more than 30% after the company lowered its fiscal year forecasts
The Dexcom logo is seen on a smartphone screen and in the background. Pavlo Gonchar | SOPA Images | Lightrocket…
Viking Therapeutics shares rise on plans to test weight-loss injection
Weight loss drug concept. Cr | Istock | Getty Images Actions of Viking Therapeutics rose more than 20% on Thursday…